Based in Germany, Acousia is a startup founded in 2012. Brouky records 2 investors associated with the company.
Acousia develops novel small molecule therapeutics to enhance and preserve natural hearing in patients with sensorineural hearing loss (SNHL), addressing a major unmet medical need.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.